Tag

HIV Research

The Fenway Institute is now recruiting for a study around HIV linkage to care.

Study Explores New HIV Linkage to Care Model

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, Research, The Fenway Institute | No Comments
According to the U.S. Centers for Disease Control and Prevention, MSM continue to be the group most heavily affected by HIV in the US; while they represent only two percent of the U.S. population, MSM account for nearly 67% of newly diagnosed HIV infections. That burden is even heavier for gay and bisexual African American men. The CDC reports that from 2005 to 2014, the number of new HIV diagnoses among young African American gay and bisexual men increased 87%. These troubling numbers highlight the need for a variety linkage to care models to ensure that these men regularly take 
Read More
aids2016

The Fenway Institute Represents at AIDS 2016 in Durban, South Africa

By | Fenway News, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
Digital technologies. Social networks. Breakthroughs in habit formation. Advances in medical therapy. These are some of the innovative tools that scientists and researchers at The Fenway Institute are exploring to fight the HIV pandemic here at home and around the world. Next week, a team of five Fenway scientists and researchers led by Kenneth H. Mayer, M.D., Medical Research Director and Co-Chair of The Fenway Institute, will bring their latest findings to the International AIDS Conference in Durban, South Africa. The annual event features experts in science, public policy, and public health presenting new research in HIV treatment, prevention, and 
Read More
Kenneth Mayer, MD, Co-Chair and Medical Research Director at The Fenway Institute, has been honored by the HIV Prevention Trials Network.

Fenway’s Dr. Kenneth Mayer Receives HPTN’s Ward Cates Spirit Award

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
We are thrilled to announce that Kenneth Mayer, MD, Co-Chair and Medical Research Director at The Fenway Institute, has been honored by the HIV Prevention Trials Network (HPTN) with its first ever Ward Cates Spirit Award. This award recognizes a Network member who has made outstanding contributions to HPTN’s mission through public health advocacy, leadership, and mentoring. The Spirit Award is named for Willard (Ward) Cates Jr., MD, MPH, Distinguished Scientist and President Emeritus of FHI 360 and Principal Investigator of HIVNET’s International Master Contractor and HPTN from 1994 to 2006. Cates passed away in March of 2016. Winners of 
Read More
A new study aims to address the unique HIV and STI prevention needs of young transgender men who have sex with men.

Spotlighting HIV/STI Prevention For Transgender Men

By | Fenway Health Newsroom, HIV/AIDS, HIV/AIDS, The Fenway Institute, Trans | No Comments
Transgender men and transmasculine individuals are all too often left out of the conversation around HIV and STI prevention. A new report led by researchers from The Fenway Institute hopes to address this knowledge gap by outlining the specific sexual health needs of this overlooked demographic. The report, titled LifeSkills for Men (LS4M): Pilot Evaluation of a Gender-Affirmative HIV and STI Prevention Intervention for Young Adult Transgender Men Who Have Sex with Men, is published in the Journal of Urban Health and is the first of its kind to explore HIV and STI prevention interventions focused on young adult transgender 
Read More
On World AIDS Day 2015, we pause to reflect on the progress made and the work still to be done to end the global HIV/AIDS epidemic.

Fenway Health Observes World AIDS Day 2015

By | Fenway Health Newsroom, HIV/AIDS | No Comments
December 1st marks World AIDS Day – a time each year when we pause to reflect on the incredible progress made in the global battle against HIV/AIDS, and recommit to continue the fight until the epidemic is over. Though this disease is no longer the almost certain death sentence it once was, every new infection is one infection too many. For those with the means to access lifesaving medication, HIV/AIDS is a manageable chronic condition, but still one that can affect everyday life. For those who face financial, social, and geographical barriers to treatment, AIDS still claims lives around the 
Read More